Industry Outlook
The global foot and mouth disease (FMD) vaccines market to reach US$ 2,935.1 Mn in 2026 and projected to exhibit a compound annual growth rate (CAGR) of 8.1% during the forecast period from 2018 to 2026. FMD is highly contagious viral disease and sometimes fatal affecting cloven hoofed animals that includes domestic and wild bovids. Control and prevention of FMD needs vaccination, continuous monitoring, trade restrictions and isolations, or elimination of millions of animals to prevent the spread of the disease. The World Organization of Animal Health (OIE) classifies countries with the following stages with regards to FMD such as FMD present with or without vaccination, FMD free without vaccination and FMD free with vaccination. Countries classified as FMD-free without vaccination have the highest export for animal derived components; therefore these countries strive hard for maintain their current status by preventing the FMD viruses. Favorable government initiatives to prevent and restrict the FMD outbreaks have boosted the demand for FMD vaccines market. High prevalence of foot and mouth diseases in developing countries in Asia Pacific and Latin America are also assisting the steady growth of FMD vaccines market. Asia Pacific held the largest share in the global FMD vaccines market owing to the large number of cattle and dairy animals in developing countries such as India, Bangladesh, China, Hong Kong and Pakistan which as susceptible to FMD endemics. The FMD vaccines market consists of large number of local players operating in the market. Moreover, government subsidies and funding for vaccines production and consumptions have restricted the entry of large pharmaceutical companies to venture in the market.
Growing Demand for Oil-based Vaccines to Drive the Market
In 2017, conventional vaccines held the largest share in the global FMD vaccines market in terms of vaccine type. The rise in preventive vaccination programs in FMD endemic prone areas and developed countries such as U.S., Canada, and U.K. will continue to boost the market for conventional vaccines market during the forecast period. Conventional vaccines are further segmented in to aluminum hydroxide/saponin based vaccines and oil-based vaccines. The oil-based vaccines are anticipated to grow at the fastest rate during the forecast period from 2018 to 2026 owing to advantages associated with oil-based FMD such as initiation of high titers and longer antibody responses resulting in better protection. Emergency vaccines are also expected to grow at a steady rate during the forecast period owing to the growing cases of FMD in the developing region.
Asia Pacific to Lead the Foot and Mouth Disease Vaccines Market
In 2017, Asia Pacific held the largest share in the global FMD vaccines market owing to the presence of developing nations with high headcount of cattle, pigs and sheep those are susceptible for FMD viruses. Agriculture and dairy industry is one of the prime industries in countries such as India, China, Bangladesh, and Pakistan; hence, regular vaccination drives are conducted by government to prevent outbreak of FMD that would affect the dairy and agriculture industries. According to OIE the direct and indirect losses associated with FMD is approximately US$ 5 billion globally. The impact of FMD has led to the successful campaigns of disease eradication in developed regions in North America and Europe. Minimum cases of FMD in have been recorded in these regions, hence; FMD vaccines market will exhibit sluggish growth rate in the North America and Europe compared to other regions in the market.
Historical & Forecast Period
This research report presents the analysis of each segment from 2016 to 2026 considering 2017 as the base year for the research. Compounded annual growth rate (CAGR) for each respective segments calculated for the forecast period from 2018 to 2026.
Market is studied in order to understand the current and future market trends in the foot and mouth disease vaccines market. The market is estimated by providing the compounded annual growth rate (CAGR) and data forecast from 2018 to 2026. Strategic merger, acquisition and collaboration among the key players for developing innovative product pipeline mentioned in the business strategy section. The key players currently engaged in the foot and mouth disease market are Merck Animal Health, Brilliant Bio Pharma Ltd., Agrovet Co., Indian Immunologics Limited, Merial S.A.S, Inova Biotecnologia, Intervac (Pvt). Ltd among others.
Key questions answered in this report
Chapter 1. Preface
1.1. Report Description
1.1.1. Study Purpose
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Primary Research
1.3.3. Phase III – Expert Panel Review
1.3.4. Assumptions
1.4. Market Segmentation
Chapter 2. Executive Summary
2.1. Global FMDV Market Portraiture
2.2. Global FMDV Market, by Vaccine Type, 2017 (US$ Mn)
2.3. Global FMDV Market, by Animal Type, 2017 (US$ Mn)
2.4. Global FMDV Market, by Geography, 2017 (US$ Mn)
Chapter 3. Foot and Mouth Disease Vaccines (FMDV) Market Dynamics and Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2017
3.6. Competitive Analysis: Global FMDV Market, by Key Players, 2017
Chapter 4. Global Foot and Mouth Disease Vaccines (FMDV) Market, by Vaccine Type, 2016-2026 (US$ Mn)
4.1. Overview
4.2. Conventional Vaccines
4.2.1. Aluminum Hydroxide/Saponin based Vaccines
4.2.2. Oil-based Vaccine
4.3. Emergency Vaccines
Chapter 5. Global Foot and Mouth Disease Vaccines (FMDV) Market, by Animal Type, 2016-2026 (US$ Mn)
5.1. Overview
5.2. Cattle
5.3. Sheep & Goat
5.4. Swine
5.5. Others (Deer, Antelope, Gazelle)
Chapter 6. Global Foot and Mouth Disease Vaccines (FMDV) Market, by Geography, 2016 – 2026 (US$ Mn)
6.1. North America FMDV Market Analysis, 2016 – 2026
6.1.1. North America FMDV Market, by Vaccine Type, 2016 - 2026 (US$ Mn)
6.1.2. North America FMDV Market, by Animal Type, 2016 - 2026 (US$ Mn)
6.1.3. North America FMDV Market, by Country, 2016 – 2026 (US$ Mn)
6.1.3.1. U.S.
6.1.3.2. Canada
6.2. Europe FMDV Market Analysis, 2016 – 2026
6.2.1. Europe FMDV Market, by Vaccine Type, 2016 - 2026 (US$ Mn)
6.2.2. Europe FMDV Market, by Animal Type, 2016 - 2026 (US$ Mn)
6.2.3. Europe FMDV Market, by Country, 2016 – 2026 (US$ Mn)
6.2.3.1. U.K.
6.2.3.2. Germany
6.2.3.3. Rest of Europe
6.3. Asia Pacific FMDV Market Analysis, 2016 – 2026
6.3.1. Asia Pacific FMDV Market, by Vaccine Type, 2016 - 2026 (US$ Mn)
6.3.2. Asia Pacific FMDV Market, by Animal Type, 2016 - 2026 (US$ Mn)
6.3.3. Asia Pacific FMDV Market, by Country, 2016 – 2026 (US$ Mn)
6.3.3.1. China
6.3.3.2. Japan
6.3.3.3. India
6.3.3.4. Rest of Asia Pacific
6.4. Latin America FMDV Market Analysis, 2016 – 2026
6.4.1. Latin America FMDV Market, by Vaccine Type, 2016 - 2026 (US$ Mn)
6.4.2. Latin America FMDV Market, by Animal Type, 2016 - 2026 (US$ Mn)
6.4.3. Latin America FMDV Market, by Country, 2016 – 2026 (US$ Mn)
6.4.3.1. Brazil
6.4.3.2. Mexico
6.4.3.3. Rest of Latin America
6.5. Middle East & Africa FMDV Market, 2016 – 2026
6.5.1. Middle East & Africa FMDV Market, by Vaccine Type, 2016 - 2026 (US$ Mn)
6.5.2. Middle East & Africa FMDV Market, by Animal Type, 2016 - 2026 (US$ Mn)
6.5.3. Middle East & Africa FMDV Market, by Country, 2016 – 2026 (US$ Mn)
6.5.3.1. GCC
6.5.3.2. Rest of Middle East & Africa
Chapter 7. Company Profiles
7.1. India Immunological Ltd.
7.1.1. Business Description
7.1.2. Financial Information (Subject to Data Availability)
7.1.3. Product Portfolio
7.1.4. News Coverage
7.2. Merck Animal Health
7.3. Brilliant Bio Pharma Ltd.
7.4. Agrovet Co.
7.5. Merial S.A.S
7.6. Inova Biotecnologia
7.7. Intervac (Pvt). Ltd.
7.8. China Animal Husbandry Co., Ltd.
7.9. Biogénesis-Bagó S.A.
7.10. Vetal Animal Health Products S.A.
* FMDV - Foot and Mouth Disease Vaccines
Note:
Modification in the list of company profiles or scope of the study can be incorporated on request.
TABLE 1 Global Foot and Mouth Disease Vaccines (FMDV) Market Portraiture
TABLE 2 Global FMDV Market, by Vaccine Type, 2016 – 2026 (US$ Mn)
TABLE 3 Global FMDV Market, by Animal Type, 2016 – 2026 (US$ Mn)
TABLE 4 Global FMDV Market, by Geography, 2016 – 2026 (US$ Mn)
TABLE 5 North America FMDV Market, by Vaccine Type, 2016 – 2026 (US$ Mn)
TABLE 6 North America FMDV Market, by Animal Type, 2016 – 2026 (US$ Mn)
TABLE 7 North America FMDV Market, by Country, 2016 – 2026 (US$ Mn)
TABLE 8 Europe FMDV Market, by Vaccine Type, 2016 – 2026 (US$ Mn)
TABLE 9 Europe FMDV Market, by Animal Type, 2016 – 2026 (US$ Mn)
TABLE 10 Europe FMDV Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 11 Asia Pacific FMDV Market, by Vaccine Type, 2016 – 2026 (US$ Mn)
TABLE 12 Asia Pacific FMDV Market, by Animal Type, 2016 – 2026 (US$ Mn)
TABLE 13 Asia Pacific FMDV Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 14 Latin America FMDV Market, by Vaccine Type, 2016 – 2026 (US$ Mn)
TABLE 15 Latin America FMDV Market, by Animal Type, 2016 – 2026 (US$ Mn)
TABLE 16 Latin America FMDV Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 17 Middle East & Africa FMDV Market, by Vaccine Type, 2016 – 2026 (US$ Mn)
TABLE 18 Middle East & Africa FMDV Market, by Animal Type, 2016 – 2026 (US$ Mn)
TABLE 19 Middle East & Africa FMDV Market, by Region, 2016 – 2026 (US$ Mn)
TABLE 20 India Immunological Ltd.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 21 Merck Animal Health: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 22 Brilliant Bio Pharma Ltd.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 23 Agrovet Co.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 24 Merial S.A.S: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 25 Inova Biotecnologia: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 26 Intervac (Pvt). Ltd.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 27 China Animal Husbandry Co., Ltd.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 28 Biogénesis-Bagó S.A.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 29 Vetal Animal Health Products S.A.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
FIG 1. Foot and Mouth Disease Vaccines (FMDV) Market: Research Methodology
FIG 2. FMDV Market Segmentation
FIG 3. Global FMDV Market, by Vaccine Type, 2017 (US$ Mn)
FIG 4. Global FMDV Market, by Animal Type, 2017 (US$ Mn)
FIG 5. Global FMDV Market, by Geography, 2017 (US$ Mn)
FIG 6. Attractive Investment Proposition, by Geography, 2017
FIG 7. Competitive Analysis: Global FMDV Market, by Key Players, 2017
FIG 8. Global Aluminum Hydroxide/Saponin based Vaccines Market, 2016-2026 (US$ Mn)
FIG 9. Global Oil-based Vaccines Market, 2016-2026(US$ Mn)
FIG 10. Global FMDV Market for Cattle, 2016-2026 (US$ Mn)
FIG 11. Global FMDV Market for Sheep & Goat, 2016-2026(US$ Mn)
FIG 12. Global FMDV Market for Swine, 2016-2026 (US$ Mn)
FIG 13. Global FMDV Market for Other Animals, 2016-2026 (US$ Mn)
FIG 14. U.S. FMDV Market, 2016-2026 (US$ Mn)
FIG 15. Canada FMDV Market, 2016-2026 (US$ Mn)
FIG 16. U.K. FMDV Market, 2016-2026 (US$ Mn)
FIG 17. Germany FMDV Market, 2016-2026 (US$ Mn)
FIG 18. Rest of Europe FMDV Market, 2016-2026 (US$ Mn)
FIG 19. China FMDV Market, 2016-2026 (US$ Mn)
FIG 20. Japan FMDV Market, 2016-2026 (US$ Mn)
FIG 21. India FMDV Market, 2016-2026 (US$ Mn)
FIG 22. Rest of Asia Pacific FMDV Market, 2016-2026 (US$ Mn)
FIG 23. Brazil FMDV Market, 2016-2026 (US$ Mn)
FIG 24. Mexico FMDV Market, 2016-2026 (US$ Mn)
FIG 25. Rest of Latin America FMDV Market, 2016-2026 (US$ Mn)
FIG 26. GCC FMDV Market, 2016-2026 (US$ Mn)
FIG 27. Rest of Middle East & Africa FMDV Market, 2016-2026 (US$ Mn)